Recently, sequencing studies have demonstrated the presence of recurrent mutations in systemic ALK− ALCL, which include PRDM1/BLIMP1, TP53, STAT3, JAK1, and BANK1 [58]. The gene discussed is TP53; the disease is anaplastic large cell lymphoma.